Associations between the levels of sclerostin, phosphate, and fibroblast growth factor-23 and treatment with vitamin D in hemodialysis patients with low intact PTH level.

Asamiya, Y; Yajima, A; Shimizu, S; Otsubo, S; Tsuchiya, K; Nitta, K

Asamiya, Y; Yajima, A; Shimizu, S; Otsubo, S; Tsuchiya, K; Nitta, K.

Affiliation

Asamiya Y; Department of Medicine, Kidney Center, Tokyo Women's Medical University, 8-1 Kawada-chou, Shinjuku-ku, Tokyo, 162-8666, Japan, asamiyaasamiya@gmail.com.

Osteoporos Int ; 26(3): 1017-28, 2015 Mar.

Article in En | MEDLINE | ID: mdl-25366373

Subject(s)

Bone Morphogenetic Proteins/blood; Parathyroid Hormone/deficiency; Renal Dialysis; Vitamin D/therapeutic use; Adaptor Proteins, Signal Transducing; Adult; Aged; Biomarkers/blood; Case-Control Studies; Dietary Supplements; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors/blood; Genetic Markers; Humans; Kidney Failure, Chronic/blood; Kidney Failure, Chronic/therapy; Male; Middle Aged; Parathyroid Hormone/blood; Phosphates/blood; Young Adult

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Parathyroid Hormone / Vitamin D / Renal Dialysis / Bone Morphogenetic Proteins Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Osteoporos Int Year: 2015 Type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google